EUA
Inform Diagnostics SARS-CoV-2 RT-PCR Assay
FDA Emergency Use Authorization · Inform Diagnostics, Inc. · Jun 26, 2020
Key facts
| Product | Inform Diagnostics SARS-CoV-2 RT-PCR Assay |
|---|---|
| Company | Inform Diagnostics, Inc. |
| Product type | Real-time RT-PCR, Multiple Targets |
| Date | Jun 26, 2020 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: